Ann Arbor real-world evidence company providing data analytics and insights to pharmaceutical and biotech companies.
Founded in 2007 and headquartered in Ann Arbor, US, STATinMED Research provides real-world evidence solutions that combine in-house and commercial data with analytics and publication services. It covers more than 20 therapeutic areas and has produced more than 1,000 peer-reviewed publications. Its clients include 22 of the top 25 pharmaceutical companies. Ancor Capital Partners acquired the company in September 2018, with co-investments from Capital Southwest Corporation, CION Investments, Harbert Management Corporation and Dos Rios Partners. Wendy Shusko is CEO.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in